Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 2/2008

01.03.2008 | Original Article

Opioid use determines success of videothoracoscopic splanchnicectomy in chronic pancreatic pain patients

verfasst von: Tomasz Stefaniak, Ad Vingerhoets, Wojciech Makarewicz, Lukasz Kaska, Jarek Kobiela, Barbara Kwiecińska, Aleksander Stanek, Andrzej J. Lachinski, Zbigniew Śledziński

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective

Videoscopic splanchnicectomy (VSPL) is a method of pain relief in chronic pancreatitis patients. Because this method is not equally effective in all patients, this study was designed to identify the factors determining the unfavorable results of VSPL.

Materials and methods

This is a non-randomized prospective case-controlled study designed to compare a group of patients suffering from chronic pancreatitis treated with VSPL (N = 48) versus a group of patients treated symptomatically (N = 42). The outcome was measured as the intensity of pain ailments [visual analog scale (VAS)-pain scale] and subjective satisfaction of the patients from the surgical treatment [Functional Assessment of Chronic Illness Therapy-Treatment Satisfaction (FACIT-TS)]. The predictive variables considered in this study were: age, sex, emotional status, social support (the two last variables were measured by subscales of quality-of-life questionnaire from the group of FACIT), history of previous surgical treatment, and opioid use for at least 3 months before VSPL. The follow-up was 18 months. Logistic regression was performed using dichotomized pain as outcome variable: high score more than 66.7 on VAS scale and low under 50 points on VAS scale 18 months after VSPL.

Results

VSPL significantly reduced the pain ailments at all points of the study when compared to the control. However, the pain intensity at the end of the study was higher than directly after the surgery. In the patients treated with opioids before the surgery, the pain intensity was significantly higher than in the patients not using this group of drugs. Logistic regression revealed that opioid administration before VSPL was the most important predictor of high pain scores 18 months after the surgery.

Conclusion

When planning the VSPL in the treatment of pain in patients suffering from chronic pancreatitis, it is necessary to take into consideration the previous chronic use of opioids, as this variable can significantly influence poorer results of this surgical pain management.
Literatur
1.
Zurück zum Zitat Saenz A, Kuriansky J, Salvador L, Astudillo E, Cardona V, Shabtai M, Fernandez-Cruz L (2000) Thoracoscopic splanchnicectomy for pain control in patients with unresectable carcinoma of the pancreas. Surg Endosc 14(8):717–720PubMedCrossRef Saenz A, Kuriansky J, Salvador L, Astudillo E, Cardona V, Shabtai M, Fernandez-Cruz L (2000) Thoracoscopic splanchnicectomy for pain control in patients with unresectable carcinoma of the pancreas. Surg Endosc 14(8):717–720PubMedCrossRef
2.
Zurück zum Zitat Stefaniak T, Basinski A, Vingerhoets A, Makarewicz W, Connor S, Kaska L, Stanek A, Kwiecinska B, Lachinski AJ, Sledzinski Z (2005) A comparison of two invasive techniques in the management of intractable pain due to inoperable pancreatic cancer: neurolytic celiac plexus block and videothoracoscopic splanchnicectomy. Eur J Surg Oncol 31(7):768–773PubMedCrossRef Stefaniak T, Basinski A, Vingerhoets A, Makarewicz W, Connor S, Kaska L, Stanek A, Kwiecinska B, Lachinski AJ, Sledzinski Z (2005) A comparison of two invasive techniques in the management of intractable pain due to inoperable pancreatic cancer: neurolytic celiac plexus block and videothoracoscopic splanchnicectomy. Eur J Surg Oncol 31(7):768–773PubMedCrossRef
3.
Zurück zum Zitat Bradley EL 3rd, Bem J (2003) Nerve blocks and neuroablative surgery for chronic pancreatitis. World J Surg 27(11):1241–1248PubMedCrossRef Bradley EL 3rd, Bem J (2003) Nerve blocks and neuroablative surgery for chronic pancreatitis. World J Surg 27(11):1241–1248PubMedCrossRef
4.
Zurück zum Zitat Ihse I, Zoucas E, Gyllstedt E, Lillo-Gil R, Andren-Sandberg A (1999) Bilateral thoracoscopic splanchnicectomy: effects on pancreatic pain and function. Ann Surg 230(6):785–790PubMedCrossRef Ihse I, Zoucas E, Gyllstedt E, Lillo-Gil R, Andren-Sandberg A (1999) Bilateral thoracoscopic splanchnicectomy: effects on pancreatic pain and function. Ann Surg 230(6):785–790PubMedCrossRef
5.
Zurück zum Zitat Makarewicz W, Stefaniak T, Kossakowska M, Basinski A, Suchorzewski M, Stanek A, Gruca ZB (2003) Quality of life improvement after videothoracoscopic splanchnicectomy in chronic pancreatitis patients: case control study. World J Surg 27(8):906–911PubMedCrossRef Makarewicz W, Stefaniak T, Kossakowska M, Basinski A, Suchorzewski M, Stanek A, Gruca ZB (2003) Quality of life improvement after videothoracoscopic splanchnicectomy in chronic pancreatitis patients: case control study. World J Surg 27(8):906–911PubMedCrossRef
6.
Zurück zum Zitat Maher JW, Johlin FC, Heitshusen D (2001) Long-term follow-up of thoracoscopic splanchnicectomy for chronic pancreatitis pain. Surg Endosc 15:706–709PubMedCrossRef Maher JW, Johlin FC, Heitshusen D (2001) Long-term follow-up of thoracoscopic splanchnicectomy for chronic pancreatitis pain. Surg Endosc 15:706–709PubMedCrossRef
7.
Zurück zum Zitat Makarewicz W, Stefaniak T, Stanek A, Basinski A, Kossakowska M, Gruca Z (2002) Factors determining morbidity and effectiveness in videothoracoscopic splanchnicectomy. Zentralbl Chir 127(11):950–955PubMedCrossRef Makarewicz W, Stefaniak T, Stanek A, Basinski A, Kossakowska M, Gruca Z (2002) Factors determining morbidity and effectiveness in videothoracoscopic splanchnicectomy. Zentralbl Chir 127(11):950–955PubMedCrossRef
8.
Zurück zum Zitat Ammori BJ (2003) Pancreatic surgery in the laparoscopic era. JOP 4:187–192PubMed Ammori BJ (2003) Pancreatic surgery in the laparoscopic era. JOP 4:187–192PubMed
9.
Zurück zum Zitat Howard TJ, Swofford JB, Wagner DL et al (2002) Quality of life after bilateral thoracoscopic splanchnicectomy: long-term evaluation in patients with chronic pancreatitis. J Gastrointest Surg 6:845–852PubMedCrossRef Howard TJ, Swofford JB, Wagner DL et al (2002) Quality of life after bilateral thoracoscopic splanchnicectomy: long-term evaluation in patients with chronic pancreatitis. J Gastrointest Surg 6:845–852PubMedCrossRef
10.
Zurück zum Zitat House JS, Landis KR, Umberson D (1988) Social relationships and health. Science 241:540–545PubMedCrossRef House JS, Landis KR, Umberson D (1988) Social relationships and health. Science 241:540–545PubMedCrossRef
11.
Zurück zum Zitat Ballantyne J (2003) Chronic pain following treatment for cancer: role of opioids. Oncologist 8:567–575PubMedCrossRef Ballantyne J (2003) Chronic pain following treatment for cancer: role of opioids. Oncologist 8:567–575PubMedCrossRef
12.
Zurück zum Zitat Breivik H (2001) Opioids in cancer and chronic non-cancer pain therapy—indications and controversies. Acta Anaesthsiol Scand 45:1059–1066CrossRef Breivik H (2001) Opioids in cancer and chronic non-cancer pain therapy—indications and controversies. Acta Anaesthsiol Scand 45:1059–1066CrossRef
13.
Zurück zum Zitat Ong KS, Keng SB (2003) The biological, social, and psychological relationship between depression and chronic pain. Cranio 21(4):286–294PubMed Ong KS, Keng SB (2003) The biological, social, and psychological relationship between depression and chronic pain. Cranio 21(4):286–294PubMed
14.
Zurück zum Zitat Stefaniak T, Vingerhoets A, Babinska D, Trus M, Glowacki J, Dymecki D, Makarewicz W, Kaska L, Kobiela J, Lachinski AJ, Stanek A, Gruca Z, Sledzinski Z, Markuszewska-Proczko M (2004) Psychological factors influencing results of cholecystectomy. Scand J Gastroenterol 39(2):127–132PubMedCrossRef Stefaniak T, Vingerhoets A, Babinska D, Trus M, Glowacki J, Dymecki D, Makarewicz W, Kaska L, Kobiela J, Lachinski AJ, Stanek A, Gruca Z, Sledzinski Z, Markuszewska-Proczko M (2004) Psychological factors influencing results of cholecystectomy. Scand J Gastroenterol 39(2):127–132PubMedCrossRef
15.
Zurück zum Zitat Herbert RD (2005) Randomisation in clinical trials. Aust J Physiother 51(1):58–60PubMed Herbert RD (2005) Randomisation in clinical trials. Aust J Physiother 51(1):58–60PubMed
16.
Zurück zum Zitat Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 1:79PubMedCrossRef Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 1:79PubMedCrossRef
17.
Zurück zum Zitat Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed
18.
Zurück zum Zitat Stefaniak T, Makarewicz W, Kossakowska M, Basiński A, Reszetow J, Kobiela J, Stanek A, Łachiński A, Konarski R, Gruca Z (2003) Application of the FACIT questionnaire in the evaluation of the quality of life in patients with chronic pancreatitis: Polish conditions. Pol Przegl Chir 75(10):956–965 Stefaniak T, Makarewicz W, Kossakowska M, Basiński A, Reszetow J, Kobiela J, Stanek A, Łachiński A, Konarski R, Gruca Z (2003) Application of the FACIT questionnaire in the evaluation of the quality of life in patients with chronic pancreatitis: Polish conditions. Pol Przegl Chir 75(10):956–965
19.
Zurück zum Zitat Yuan C, Foss JF, O’Connor M, Toledano A, Roizen M, Moss J (1996) Methylnaltrexone prevents morphine-induced delay in oral–cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther 59:469–475PubMedCrossRef Yuan C, Foss JF, O’Connor M, Toledano A, Roizen M, Moss J (1996) Methylnaltrexone prevents morphine-induced delay in oral–cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther 59:469–475PubMedCrossRef
20.
Zurück zum Zitat Gan TJ, Ginsberg B, Glass PS, Fortney J, Jhaveri R, Perno R (1997) Opioidsparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology 87:1075–1081PubMedCrossRef Gan TJ, Ginsberg B, Glass PS, Fortney J, Jhaveri R, Perno R (1997) Opioidsparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology 87:1075–1081PubMedCrossRef
21.
Zurück zum Zitat Nicholson B (2003) Responsible prescribing of opioids for the management of chronic pain. Drugs 63(1):17–32PubMedCrossRef Nicholson B (2003) Responsible prescribing of opioids for the management of chronic pain. Drugs 63(1):17–32PubMedCrossRef
22.
Zurück zum Zitat Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz NP (2003) Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage 26(4):913–921PubMedCrossRef Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz NP (2003) Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage 26(4):913–921PubMedCrossRef
23.
Zurück zum Zitat Martelli MF, Zasler ND, Bender MC, Nicholson K (2004) Psychological, neuropsychological, and medical considerations in assessment and management of pain. J Head Trauma Rehabil 19(1):10–28PubMedCrossRef Martelli MF, Zasler ND, Bender MC, Nicholson K (2004) Psychological, neuropsychological, and medical considerations in assessment and management of pain. J Head Trauma Rehabil 19(1):10–28PubMedCrossRef
24.
Zurück zum Zitat Vallejo R, de Leon-Casasola O, Benyamin R (2004) Opioid therapy and immunosuppression: a review. Am J Ther 11(5):354–365PubMedCrossRef Vallejo R, de Leon-Casasola O, Benyamin R (2004) Opioid therapy and immunosuppression: a review. Am J Ther 11(5):354–365PubMedCrossRef
25.
Zurück zum Zitat WHO (1990) Cancer pain relief and palliative care. World Health Organization, Technical Report Series No 804, Geneva, Switzerland WHO (1990) Cancer pain relief and palliative care. World Health Organization, Technical Report Series No 804, Geneva, Switzerland
26.
Zurück zum Zitat Friedman JD, Dell Buono FA (2001) Opioid antagonists in the treatment of opioid-induced constipation and pruritus. Ann Pharmacother 35:85–91PubMedCrossRef Friedman JD, Dell Buono FA (2001) Opioid antagonists in the treatment of opioid-induced constipation and pruritus. Ann Pharmacother 35:85–91PubMedCrossRef
27.
Zurück zum Zitat Singh VV, Toskes PP (2003) Medical therapy for chronic pancreatitis pain. Curr Gastroenterol Rep 5:110–116PubMedCrossRef Singh VV, Toskes PP (2003) Medical therapy for chronic pancreatitis pain. Curr Gastroenterol Rep 5:110–116PubMedCrossRef
28.
Zurück zum Zitat Raith K, Hochhaus G (2004) Drugs used in the treatment of opioid tolerance and physical dependence: a review. Int J Clin Pharmacol Ther 42:191–203PubMed Raith K, Hochhaus G (2004) Drugs used in the treatment of opioid tolerance and physical dependence: a review. Int J Clin Pharmacol Ther 42:191–203PubMed
29.
Zurück zum Zitat Turk DC, Okifuji A (2002) Psychological factors in chronic pain: evolution and revolution. J Consult Clin Psychol 70(3):678–690PubMedCrossRef Turk DC, Okifuji A (2002) Psychological factors in chronic pain: evolution and revolution. J Consult Clin Psychol 70(3):678–690PubMedCrossRef
30.
Zurück zum Zitat Hanck C, Whitcomb DC (2004) Alcoholic pancreatitis. Gastroenterol Clin North Am 33(4):751–765PubMedCrossRef Hanck C, Whitcomb DC (2004) Alcoholic pancreatitis. Gastroenterol Clin North Am 33(4):751–765PubMedCrossRef
31.
Zurück zum Zitat Kreek MJ, Nielsen DA, LaForge KS (2004) Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med 5:85–108PubMedCrossRef Kreek MJ, Nielsen DA, LaForge KS (2004) Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med 5:85–108PubMedCrossRef
32.
Zurück zum Zitat Finn AK, Whistler JL (2001) Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 32:829–839PubMedCrossRef Finn AK, Whistler JL (2001) Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 32:829–839PubMedCrossRef
33.
Zurück zum Zitat South SM, Smith MT (2001) Analgesic tolerance to opioids. Pain Clin Updates 9:1–4 South SM, Smith MT (2001) Analgesic tolerance to opioids. Pain Clin Updates 9:1–4
34.
Zurück zum Zitat Mao J, Price DD, Mayer DJ (1995) Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62:259–274PubMedCrossRef Mao J, Price DD, Mayer DJ (1995) Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62:259–274PubMedCrossRef
Metadaten
Titel
Opioid use determines success of videothoracoscopic splanchnicectomy in chronic pancreatic pain patients
verfasst von
Tomasz Stefaniak
Ad Vingerhoets
Wojciech Makarewicz
Lukasz Kaska
Jarek Kobiela
Barbara Kwiecińska
Aleksander Stanek
Andrzej J. Lachinski
Zbigniew Śledziński
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 2/2008
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-007-0177-2

Weitere Artikel der Ausgabe 2/2008

Langenbeck's Archives of Surgery 2/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.